Restoring of miR-193a-5p Sensitizes Breast Cancer Cells to Paclitaxel through P53 Pathway

Monireh Khordadmehr ¹ * , Roya Shahbazi ¹, Behzad Baradaran ^2,3 * , Sanam Sadreddini ², Dariush Shanebandi ², Khalil Hajiasgharzadeh ²

Cited by CrossRef: 11

1- Ghafouri-Fard S, Shoorei H, Abak A, Abbas Raza S, Pichler M, Taheri M. Role of non-coding RNAs in modulating the response of cancer cells to paclitaxel treatment. Biomedicine & Pharmacotherapy. 2021;134:111172 [Crossref]

2- Mahabady M, Mirzaei S, Saebfar H, Gholami M, Zabolian A, Hushmandi K, Hashemi F, Tajik F, Hashemi M, Kumar A, Aref A, Zarrabi A, Khan H, Hamblin M, Nuri Ertas Y, Samarghandian S. Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity. Journal Cellular Physiology. 2022;237(5):2309 [Crossref]

3- Azzarito G, Henry M, Rotshteyn T, Leeners B, Dubey R. Transcriptomic and Functional Evidence That miRNA193a-3p Inhibits Lymphatic Endothelial Cell (LEC) and LEC + MCF-7 Spheroid Growth Directly and by Altering MCF-7 Secretome. Cells. 2023;12(3):389 [Crossref]

4- Khordadmehr M, Matin R, Baradaran B, Baghbani E, Jigari-Asl F, Noorolyai S. The Effect of miR-4800 Restoration on Proliferation and Migration of Human Breast Cancer Cells In Vitro. Adv Pharm Bull. 2023;13(2):378 [Crossref]

5- Xu S, Luo W, Li M, Li Q, Hong W, Gao Y, Yang J, Song H, Chen L, Yang Y, Yang C. Circ_0001667 Promotes Adriamycin Resistance and Malignant Progression via Targeting the miR-193a-5p/Rap2A Molecular Axis in Breast Cancer. Clinical Breast Cancer. 2023;23(1):71 [Crossref]

6- Wang Y, Li N, Zhao J, Dai C. MiR-193a-5p serves as an inhibitor in ovarian cancer cells through RAB11A. Reproductive Toxicology. 2022;110:105 [Crossref]

7- Yao Y, Shi L, Zhu X. Four differentially expressed exosomal miRNAs as prognostic biomarkers and therapy targets in endometrial cancer: Bioinformatic analysis. 2023;102(34):e34998 [Crossref]

8- Tian T, Han J, Huang J, Li S, Pang H. Hypoxia-Induced Intracellular and Extracellular Heat Shock Protein gp96 Increases Paclitaxel-Resistance and Facilitates Immune Evasion in Breast Cancer. Front Oncol. 2021;11 [Crossref]

9- Guaraldi F, Morandi L, Zoli M, Mazzatenta D, Righi A, Evangelisti S, Ambrosi F, Tonon C, Giannini C, Lloyd R, Asioli S. Epigenomic and somatic mutations of pituitary tumors with clinical and pathological correlations in 111 patients. Clinical Endocrinology. 2022;97(6):763 [Crossref]

10- Tan L, Chen Z, Yuchi A. miR-193a-5p Enhances the Radioresistance of Pancreatic Cancer Cells by Targeting ZFP57 and Activating the Wnt Pathway. Journal of Oncology. 2022;2022:1 [Crossref]

11- Fuhrmann D, Brüne B. miR-193a-3p increases glycolysis under hypoxia by facilitating Akt phosphorylation and PFKFB3 activation in human macrophages. Cell Mol Life Sci. 2022;79(2) [Crossref]